Pulmonary Function Testing Systems Market Statistics Insights 2028

The pulmonary function testing systems market size is expected to reach US$ 401.83 million by 2028 from US$ 274.10 million in 2022. The pulmonary function testing systems market is estimated to record a CAGR of 6.6% from 2022 to 2028.

Pulmonary functioning testing (PFT) is a set of noninvasive tests used to measure how well a patient’s lungs are working. These tests are important in diagnosing and treating those with respiratory diseases. In order to perform the tests and obtain accurate results, it is important to use the right types of PFT equipment and machines. The pulmonary functioning testing system is made up of several devices that are used to measure different aspects of lung function. This can include how well the lungs take in and expel air, how efficiently they transfer oxygen to the blood, and how much air they can hold. PFTs measure lung volumes, capacities, and the amount of gas exchange. The rising incidence of lung-related disorders and occupational lung diseases is contributing to the growing pulmonary function testing systems market size. However, the risk of cross-contamination and the lack of skilled professionals are hampering the market growth.

The pulmonary function testing systems market has been segmented based on type, test type, component, application, end user, and geography. In terms of geography, the market is primarily segmented into North America, Europe, Asia Pacific, the Middle East & Africa, and South & Central America. The report offers insights and in-depth analysis of the market, emphasizing parameters such as pulmonary function testing systems market trends, technological advancements, market dynamics, and the competitive landscape analysis of leading market players.

Customize This Report To Suit Your Requirement

You will get customization on any report - free of charge - including parts of this report, or country-level analysis, Excel Data pack, as well as avail great offers and discounts for start-ups & universities

Get FREE CUSTOMIZATION

Pulmonary Function Testing Systems Market: Strategic Insights

• Get Top Key Market Trends of this report.
  This FREE sample will include data analysis, ranging from market trends to estimates and forecasts.

Free Sample PDF

Market Insights

Rising Incidence of Lung-Related Disorders

According to the British Lung Foundation 2023 report, ~10,000 people in the UK are newly diagnosed with lung disease every week. Additionally, lung diseases account for more than 70,00,000 hospital admissions, with 6 million inpatient bed-days in the UK annually. Therefore, pulmonary function testing (PFT) systems prove useful in diagnosing and monitoring. The PFT systems provide accurate results, particularly lung volume, capacity, rates of flow, and gas exchange. Additionally, PFT systems utilization assists in assessing treatment for asthma, emphysema, and other chronic lung problems. Through the assessment of lung volumes, capacities, rates of flow, and gas exchange, PFTs can provide information that can be evaluated by physicians to help diagnose certain lung disorders effectively and decide the right treatment for patients. Further, PFTs are noninvasive procedures and are usually recommended by physicians for patients with no hospital stay. Commercial pulmonary function testing systems available in the market include spirometry. Spirometry testing is useful for determining if the patient is suffering from lung disease, type of lung disease, progression of the lung disease, and impairment of lung disease. Spirometry measures airflow and can evaluate a broad range of lung diseases among patients. Thus, the rising incidence of lung-related disorders is fueling the use of pulmonary function testing systems.

Type-Based Insights

Based on type, the pulmonary function testing systems market is segmented into cart-based PFT systems and stationary PFT systems. The cart-based segment held a larger share of the market in 2022. Moreover, the cart-based segment is anticipated to register a higher CAGR in the market during the forecast period.

Test Type-Based Insights

In terms of test type, the pulmonary function testing systems market has been segmented into spirometry, lung volume, gas exchange testing, maximal voluntary ventilation, oxygen titration tests, and others. The spirometry segment held the largest share of the market in 2022. Moreover, the lung volume segment is anticipated to register the highest CAGR in the market during the forecast period.

Component-Based Insights

Based on component, the pulmonary function testing systems market has been segmented into hardware, software, and services. The hardware segment held the largest share of the market in 2022. The software segment is anticipated to register the highest CAGR in the market during the forecast period.

Application-Based Insights

Based on application, the pulmonary function testing systems market has been segmented into chronic obstructive pulmonary disease (COPD), asthma, chronic shortness of breath, restrictive lungs diseases, and others. The chronic obstructive pulmonary disease (COPD) segment held the largest share of the market in 2022. Moreover, the same segment is anticipated to register the highest CAGR in the market during the forecast period.

End User-Based Insights

Based on end user, the pulmonary function testing systems market has been segmented into hospitals, specialty clinics, and diagnostic centers. The hospitals segment held the largest share of the market in 2022. The specialty clinics segment is anticipated to register the highest CAGR in the market during the forecast period.

COVID-19 is a respiratory system infection that may rapidly cause pneumonia-like symptoms and chest infections. This may result in lowering the health conditions of the patient. The ventilators help manage the gas exchange of the patients. Due to the COVID-19 outbreak, there was a very high demand for pulmonary function testing systems. American Lung Association and Centers for Disease Control and Prevention recommended that patients with mild symptoms of COVID-19 carry out pulmonary function testing to check the lung capacity of the patient. Pulmonary function testing is an ideal tool for assessing the physiological impact of a virus that largely attacks the cardiopulmonary system. The technology measuring airflow, lung volumes, and the ability for oxygen and carbon dioxide to transfer between the alveoli and the bloodstream are well established, and facilities to perform these tests are found around the US.

Companies in the pulmonary function testing systems market commonly adopt product launches and expansion strategies to expand their footprint across the world and meet the growing demand. Their focus on product innovation allows them to cater to changing customer demands and maintain their brand name across the globe.

• In June 2022, ndd Medical Technologies (ndd) updated the entire EasyOne product range, including the EasyOne Air, Easy on-PC, EasyOne Pro, and EasyOne Pro LAB, to be compliant with the ATS/ERS Standardization of Spirometry 2019.
• In April 2021, Vyaire Medical announced the European launch of ArtiQ.PFT, an automated tool driven by artificial intelligence that instantly interprets pulmonary function tests (PFTs). ArtiQ.PFT is the first cloud-based PFT solution that leverages artificial intelligence.

In terms of geography, the global pulmonary function testing systems market is segmented into North America (the US, Canada, and Mexico), Europe (France, Germany, the UK, Spain, Italy, and the Rest of Europe), Asia Pacific (China, India, Japan, Australia, South Korea, and the Rest of APAC), the Middle East & Africa (Saudi Arabia, the UAE, South Africa, and the Rest of MEA), and South & Central America (Brazil, Argentina, and the Rest of South & Central America).

Pulmonary Function Testing Systems Market Regional Insights

The regional trends and factors influencing the Pulmonary Function Testing Systems Market throughout the forecast period have been thoroughly explained by the analysts at Insight Partners. This section also discusses Pulmonary Function Testing Systems Market segments and geography across North America, Europe, Asia Pacific, Middle East and Africa, and South and Central America.

Pulmonary Function Testing Systems Market Report Scope

Pulmonary Function Testing Systems Market Players Density: Understanding Its Impact on Business Dynamics

The Pulmonary Function Testing Systems Market market is growing rapidly, driven by increasing end-user demand due to factors such as evolving consumer preferences, technological advancements, and greater awareness of the product's benefits. As demand rises, businesses are expanding their offerings, innovating to meet consumer needs, and capitalizing on emerging trends, which further fuels market growth.

Market players density refers to the distribution of firms or companies operating within a particular market or industry. It indicates how many competitors (market players) are present in a given market space relative to its size or total market value.

Major Companies operating in the Pulmonary Function Testing Systems Market are:

1. SCHILLER
2. COSMED srl
3. MGC Diagnostics Corporation
4. Ganshoran Medizin Electronic
5. ndd Medical Technologies

Disclaimer: The companies listed above are not ranked in any particular order.

Company Profiles

• COSMED Srl
• MGC Diagnostics Corp
• Morgan Scientific Inc
• Minato Medical Science Co Ltd
• Schiller AG
• Chest MI Inc
• Vyaire Medical Inc
• ndd Medical Technologies Inc
• PulmOne Advanced Medical Devices Ltd
• KoKo PFT Ltd